International Cancer Genome Consortium, Hudson TJ, Anderson W, et al. International network of cancer genome projects. Nature. 2010;464(7291):993-8. doi:10.1038/nature08987
Lander ES, Botstein D. Strategies for studying heterogeneous genetic traits in humans by using a linkage map of restriction fragment length polymorphisms. Proc Natl Acad Sci U S A. 1986;83(19):7353-7.
McCarroll SA, Altshuler DM. Copy-number variation and association studies of human disease. Nat Genet. 2007;39(7 Suppl):S37-42. doi:10.1038/ng2080
Johannessen CM, Clemons PA, Wagner BK. Integrating phenotypic small-molecule profiling and human genetics: the next phase in drug discovery. Trends Genet. 2015;31(1):16-23. doi:10.1016/j.tig.2014.11.002
Patterson N, Price AL, Reich D. Population structure and eigenanalysis. PLoS Genet. 2006;2(12):e190. doi:10.1371/journal.pgen.0020190
de Bakker PIW, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet. 2006;38(10):1166-72. doi:10.1038/ng1885
Altshuler D. 2011 Curt Stern Award address. Am J Hum Genet. 2012;90(3):407-9. doi:10.1016/j.ajhg.2012.02.017
Plenge RM, Scolnick EM, Altshuler D. Validating therapeutic targets through human genetics. Nat Rev Drug Discov. 2013;12(8):581-94. doi:10.1038/nrd4051
Samocha KE, Robinson EB, Sanders SJ, et al. A framework for the interpretation of de novo mutation in human disease. Nat Genet. 2014;46(9):944-50. doi:10.1038/ng.3050
Carrington M, Bashirova AA, McLaren PJ. On stand by: host genetics of HIV control. AIDS. 2013;27(18):2831-9. doi:10.1097/01.aids.0000432536.85335.c8